v3.26.1
Financial Instruments
6 Months Ended
Jun. 30, 2026
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments Financial Instruments
The following table shows the Company’s cash, cash equivalents and marketable debt securities by significant investment category:
As of June 30, 2026
Amortized CostUnrealized Gains
Unrealized Losses (1)
Fair ValueCash and Cash EquivalentsCurrent Marketable Debt SecuritiesNoncurrent Marketable Debt Securities
Cash$— $— $— $— $57,623 $— $— 
Level 1:
Money market funds— — — — 1,571,094 — — 
U.S. Treasury securities1,244,182 61 (4,041)1,240,202 — 699,071 541,131 
Subtotal1,244,182 61 (4,041)1,240,202 1,571,094 699,071 541,131 
Level 2 (2):
Commercial paper137,423 — (53)137,370 15,987 121,383 — 
Total $1,381,605 $61 $(4,094)$1,377,572 $1,644,704 $820,454 $541,131 

(1) There was no allowance for expected credit losses on available-for-sale marketable debt securities as of June 30, 2026 as the unrealized losses were deemed to be temporary in nature.

(2) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.

As of June 30, 2026, interest receivables related to available-for-sale marketable debt securities of $4,896 were included in marketable debt securities on the condensed consolidated balance sheets.

As of June 30, 2026, interest receivables related to marketable debt securities of $6,769 were included in prepaid expenses and other current assets on the condensed consolidated balance sheets.

The following table shows the fair value of the Company’s noncurrent marketable debt securities, by contractual maturity, as of June 30, 2026:

Due within 1 year$820,454 
Due after 1 year through 5 years541,131 
Total fair value$1,361,585 

The following tables show the Company’s cash, cash equivalents, and marketable debt securities by significant investment category:
As of December 31, 2025
Amortized CostUnrealized GainsFair ValueCash and Cash EquivalentsCurrent Marketable Debt SecuritiesNoncurrent Marketable Debt Securities
Cash$— $— $— $11,022 $— $— 
Level 1:
Money market funds— — — 777,423 — — 
U.S. Treasury securities504,008 1,123 505,131 — 320,563 184,568 
Subtotal504,008 1,123 505,131 777,423 320,563 184,568 
Level 2 (1):
Commercial paper118,907 56 118,963 — 118,963 — 
Total$622,915 $1,179 $624,094 $788,445 $439,526 $184,568 

(1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.

As of December 31, 2025, interest receivables related to available-for-sale marketable debt securities of $4,005 were included in marketable debt securities on the condensed consolidated balance sheets.

As of December 31, 2025, interest receivables related to marketable debt securities of $3,160 were included in prepaid expenses and other current assets on the condensed consolidated balance sheets.

The following table presents the fair value of the Company's contingent consideration measured on a recurring basis as of June 30, 2026:

Fair ValueQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Contingent consideration$3,110 $— $— $3,110 

The fair value of the contingent consideration was determined using an option pricing model based on the probability of achieving the earnout targets over the two-year earnout period. The contingent consideration is classified as a Level 3 fair value measurement due to the use of significant unobservable inputs, which include a calculated discount rate and expected revenue volatility. No material changes or assumptions relating to the estimated fair value of the contingent consideration were identified during the period. As of June 30, 2026, the current portion of $1,880 is reflected in accrued expenses and other and $1,230 is reflected in other liabilities on the condensed consolidated balance sheets.